March 03, 2017
The purchasers suing Merck & Co. Inc. for allegedly lying about the efficacy of its mumps inoculation in order to keep competitors from bringing their own versions of the vaccine told a Pennsylvania federal judge Thursday that GlaxoSmithKline, a third party in the suit, is not cooperating with discovery requests.
September 05, 2014
Two lawsuits accusing Merck & Co. Inc. of lying about the efficacy of its mumps inoculation in order to keep competitors from bringing their own versions of the vaccine to market will move forward, after a Pennsylvania federal judge ruled in favor of whistleblowers and direct purchasers Thursday.
June 25, 2012
Merck and Co. Inc. was hit with a putative antitrust class action in Pennsylvania federal court Friday by an Alabama medical provider alleging the pharmaceutical company lied about the efficacy rate of its mumps inoculation in an effort to keep competitors from bringing their own versions of the vaccine to market.